<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=UTF-8">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>Thierry Nouspikel CV</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 1 6 1 0 1 1 1 1 1;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:"\@PMingLiU";
	panose-1:2 1 6 1 0 1 1 1 1 1;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
h1
	{mso-style-link:"Titre 1 Car";
	margin-right:0in;
	margin-left:0in;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
h4
	{mso-style-link:"Titre 4 Car";
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
p
	{margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.Titre1Car
	{mso-style-name:"Titre 1 Car";
	mso-style-link:"Titre 1";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
span.Titre4Car
	{mso-style-name:"Titre 4 Car";
	mso-style-link:"Titre 4";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-style:italic;}
span.ti
	{mso-style-name:ti;}
.MsoChpDefault
	{font-size:10.0pt;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=en-CH link=blue vlink=purple style='word-wrap:break-word'>

<div class=WordSection1>

<h1 style='margin-left:1.0in;text-indent:.5in'><span lang=EN-US>Dr </span>Thierry
Nouspikel</h1>

<p class=MsoNormal style='margin-left:1.0in;text-indent:.5in'><i><span
lang=EN-US style='font-size:14.0pt'>MD, PhD, FAMH Medical Genetics</span></i><span
style='font-size:14.0pt'><br>
</span>&nbsp; </p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0 width=900
 style='width:675.0pt'>
 <tr style='height:13.8pt'>
  <td width=896 colspan=2 style='width:672.0pt;padding:.75pt .75pt .75pt .75pt;
  height:13.8pt'></td>
 </tr>
 <tr style='height:405.45pt'>
  <td width=648 style='width:485.9pt;padding:.75pt .75pt .75pt .75pt;
  height:405.45pt'>
  <p class=MsoNormal align=center style='text-align:center'><img width=434
  height=541 src=thn2.jpg></p>
  </td>
  <td width=246 style='width:184.6pt;padding:.75pt .75pt .75pt .75pt;
  height:405.45pt'>
  <ul style='margin-top:0in' type=disc>
   <li class=MsoNormal><span style='font-size:14.0pt'><a href="#edu">Education</a></span></li>
  </ul>
  <p class=MsoNormal style='margin-left:.5in'><span style='font-size:14.0pt'><br>
  &nbsp; </span></p>
  <ul style='margin-top:0in' type=disc>
   <li class=MsoNormal><span style='font-size:14.0pt'><a href="#pos">Previous
       Employment</a></span></li>
  </ul>
  <p class=MsoNormal style='margin-left:.5in'><span style='font-size:14.0pt'><br>
  &nbsp; </span></p>
  <ul style='margin-top:0in' type=disc>
   <li class=MsoNormal style='color:blue'><span style='font-size:14.0pt;
       color:windowtext'><a href="#research">Research Interests</a></span></li>
  </ul>
  <p class=MsoNormal style='margin-left:.5in'><span style='font-size:14.0pt'><br>
  &nbsp; </span></p>
  <ul style='margin-top:0in' type=disc>
   <li class=MsoNormal><span style='font-size:14.0pt'><a href="#teaching">Teaching</a></span></li>
  </ul>
  <p class=MsoNormal style='margin-left:.5in'><span style='font-size:14.0pt'><br>
  &nbsp; </span></p>
  <ul style='margin-top:0in' type=disc>
   <li class=MsoNormal><span style='font-size:14.0pt'>&nbsp;<a href="#pubs">Publications</a></span></li>
  </ul>
  <p class=MsoNormal style='margin-left:.5in'><br>
  &nbsp; </p>
  </td>
 </tr>
 <tr style='height:85.25pt'>
  <td width=648 style='width:485.9pt;padding:.75pt .75pt .75pt .75pt;
  height:85.25pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:14.0pt;font-family:"Arial",sans-serif'>I</span><span
  lang=EN-US style='font-family:"Arial",sans-serif'>nnovation Scientific
  Manager FAMH, <a href="https://www.genesupport.ch/">Genesupport</a>,
  Switzerland </span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:14.0pt;font-family:"Arial",sans-serif'>P</span><span
  lang=EN-US style='font-family:"Arial",sans-serif'>resident-FAMH, Swiss
  Society for Medical Genetics (<a href="http://sgmg.ch/">SGMG/SSGM</a>)</span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:14.0pt;font-family:"Arial",sans-serif'>F</span><span
  lang=EN-US style='font-family:"Arial",sans-serif'>ederal Advisory Commission
  for Genetic Testing in Humans (<a
  href="https://www.bag.admin.ch/fr/commission-federale-pour-lanalyse-genetique-humaine-cfagh">GUMEK/CFAGH</a>)</span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:14.0pt;font-family:"Arial",sans-serif'>C</span><span
  lang=EN-US style='font-family:"Arial",sans-serif'>ommission of lab directors,
  Swiss Academy of Medical Sciences (<a
  href="https://www.samw.ch/fr/Portrait/Commissions/Responsables-de-laboratoire.html">SAMW/ASSM</a>)</span></p>
  </td>
  <td width=246 style='width:184.6pt;padding:.75pt .75pt .75pt .75pt;
  height:85.25pt'>
  <p class=MsoNormal><span style='font-family:"Arial",sans-serif'>&nbsp;</span></p>
  </td>
 </tr>
</table>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<h4><a name=edu></a>Education:</h4>

<p class=MsoNormal>1980 College Claparéde, Geneva,
Switzerland.&nbsp; Baccalaureate (valedictorian). <br>
1987 University of Geneva, School of Medicine. Diploma in medicine. <br>
1992 University of Geneva, School of Medicine.&nbsp; MD degree. <br>
1996 University of Geneva, School of Sciences.&nbsp; PhD in biology <br>
&nbsp; </p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<h4><a name=pos></a>P<span lang=EN-US>revious p</span>ositions and Employment:</h4>

<p class=MsoNormal>1988-1992 MD student, Dept of Clinical Biochemistry,
University of Geneva. Dr Patrick B. Iynedjian. <br>
1992-1996 PhD student, Dept of Genetics and Microbiology, University of Geneva.
Prof Stuart G. Clakson. <br>
1996-2000 Post-doctoral fellow, Dept of Biological Sciences, Stanford University.Prof
<a href="http://www.stanford.edu/~hanawalt/">Philip C. Hanawalt</a> <br>
2001-2005 Life Sciences Research Associate, Dept of Biological Sciences, <a
href="http://www.stanford.edu">Stanford University</a><span lang=EN-US>, USA</span>.
<br>
200<span lang=EN-US>5</span>-20<span lang=EN-US>13 Assistant Professor/Lecturer,
Institute for Cancer Studies, <a href="https://sheffield.ac.uk/">University of
Sheffield</a>, UK</span>. <br>
20<span lang=FR>13</span>-20<span lang=FR>26 Chef de Clinique/Responsable
Technique, Laboratoire de Diagnostic Moléculaire et Génomique, <a
href="https://www.hug.ch/medecine-genetique">Geneva University Hospitals</a>,
Switzerland</span>. <br>
&nbsp; </p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<h4><a name=funding></a><a name=teaching></a>Teaching:</h4>

<p class=MsoNormal style='margin-left:1.0in;text-indent:-1.0in'>2003-2005
Invited lecturer in BioSci205 <i>DNA Repair and Mutagenesis</i> taught by Prof.
Hanawalt, Dept of Biological Sciences, Stanford University.</p>

<p class=MsoNormal style='margin-left:1.0in;text-indent:-1.0in'>2007-2009
Lecturer in MBB313 <i>Genome Stability and Genetic Change</i>, together with Dr
Alastair Goldman. Department of Molecular Biology and Biotechnology, University
of Sheffield.</p>

<p class=MsoNormal>2013-<span lang=EN-US>2025</span> Teaching two medical
genetics courses to 1<sup>st</sup> year medical students<span lang=EN-US>,
University of Geneva, Switzerland</span>. </p>

<p class=MsoNormal>2013-<span lang=EN-US>2025</span><span lang=EN-US> </span>Teaching
a pre-graduate genetic course in the unit<i> Respiration</i>. </p>

<p class=MsoNormal>2013-now Tutor in the problem-based learning unit<i>
Reproduction</i>. </p>

<p class=MsoNormal style='margin-left:1.0in;text-indent:-1.0in'>2015-now Tutor
in the problem-based learning unit<i> Croissance et vieillissement cellulaire</i>.</p>

<p class=MsoNormal style='margin-left:1.0in;text-indent:-1.0in'>2018-now
Teaching a pre-graduate genetic course in the unit <i>Croissance et
vieillissement cellulaire</i>.</p>

<p class=MsoNormal style='margin-left:1.0in;text-indent:-1.0in'><span
lang=EN-US>2019 Teaching a post-graduate course on genetic risk calculations to
FMH and FAMH trainees in Switzerland.</span></p>

<p class=MsoNormal style='margin-left:1.0in;text-indent:-1.0in'><span
lang=EN-US>2019-2024 Teaching a pre-graduate genetic course to 3<sup>rd</sup> year
biomedical students.</span></p>

<p class=MsoNormal style='margin-left:1.0in;text-indent:-1.0in'><span
lang=EN-US>2019-now Tutor in </span>problem-based learning unit <i>Integration</i>.</p>

<p class=MsoNormal style='margin-left:1.0in;text-indent:-1.0in'>2025 Teaching a
post-graduate genetic course for the CAS <i>Laboratory Medicine</i>. </p>

<p class=MsoNormal>&nbsp; </p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<h4><a name=research></a>Research Interests:</h4>

<p class=MsoNormal><u><span lang=EN-US>The early years</span></u></p>

<p class=MsoNormal><span lang=EN-US>Having realized during my medical studies
that I was fascinated by basic research, I undertook a MD thesis on a research
topic. Dr Patrick Iynedjian had just cloned <i>GCK</i>, the glucokinase gene
(this was before the human genome was sequenced and cloning a gene was a
significant achievement) and I studied the regulation of the <i>GCK</i>
promoter in primary rat liver cells.</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US>For my PhD thesis with Professor Stuart
Clarkson, I entered for the first time the field of DNA repair. Dr Daniel
Scherly, a post-doc in Stuarts lab, had just accidentally cloned a human gene
with strong homology to the yeast repair gene <i>RAD2</i>. I was able to show
that mutations in this gene cause Xeroderma Pigmentosum, a DNA repair disorder
characterized by deficiencies in the repair pathway known as Nucleotide
Excision Repair (NER). I subsequently identified mutations in this gene in all
known patients from XP complementation group G and the gene was therefore named
<i>XPG</i>.</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-US>The Stanford years</span></u></p>

<p class=MsoNormal><span lang=EN-US>I then moved to Stanford University, for a
post-doc with Professor Phil Hanawalt (who discovered NER). There, I studied </span>modulations
of nucleotide excision repair (NER) in<span lang=EN-US> terminally d</span>ifferentiated
cells: neurons, macrophages<span lang=EN-US> and</span> myotubes.</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal><span lang=EN-US>I described a novel DNA repair phenotype in
these cells, which downregulate NER genome-wide, except in the genes they are
actually using. This phenomenon, which I named differentiation-associated
repair (DAR), is distinct from transcription-coupled repair in that the later
only operates on the transcribed strand whereas DAR repairs both strands.</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US>I pursued this line of research as a Research
Associate at Stanford, culminating with the discovery that the
ubiquitin-activating enzyme E1 is a key control step underlying DAR.</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-US>The Sheffield years</span></u></p>

<p class=MsoNormal><span lang=EN-US>I then led a small research group in
Sheffield, consisting in two post-docs (Dr Nevila-Hyka Nouspikel and Dr Ross
Drayton) and two PhD students (Wei-Ting Lu and Kimon Lemonidis, who both
graduated brilliantly in 2011). </span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US>Together, we extended the study of DAR to:</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in'><span
style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=EN-US>Temporarily q</span>uiescent cells: lymphocytes<span lang=EN-US> and</span>
hepatocytes.</p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in'><span
style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Stem cells:
human embryonic stem cells<span lang=EN-US> and</span> cancer stem cells.</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal><span lang=EN-US>We also further dissected the control
mechanism involving E1 and investigated the potential roles of NER attenuation
and DAR persistence in:</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in'><span
style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=EN-US>G</span>enomic instability.</p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in'><span
style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=EN-US>T</span>umorigenesis<span lang=EN-US>.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in'><span
style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=EN-US>N</span>eurodegenerative disorders.</p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in'><span
style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Potential
as a model system to study the early stages in carcinogenesis.</p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in'><span
style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Possible
use to potentiate chemotherapeutic agents.</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal><u><span lang=EN-US>The HUG years</span></u></p>

<p class=MsoNormal><span lang=EN-US>The return to my home country, Switzerland,
in 2013 was the occasion of a major career change: I moved from basic research
to a diagnostic genetics laboratory at Geneva University Hospitals.</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US>Aside from routine (and not-so-routine)
genetic testing, </span>I developed an interest for cell-free circulating DNA
and its <span lang=EN-US>clinical </span>application<span lang=EN-US>s for:</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in'><span
style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=EN-US>Cancer: Screening, remote genetic analysis of tumor cells (liquid
biopsy), therapy validation and residual disease monitoring</span>.</p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in'><span
style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=EN-US>Noninvasive prenatal testing: Not just for aneuploidy screening but
also to detect familial point mutation in the fetus, from a maternal blood
sample</span>.</p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in'><span
style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=EN-US>Organ transplants: early detection of rejection.</span></p>

<p class=MsoNormal>&nbsp;</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<h4><a name=pubs></a><a name=group></a>Selected Publications:</h4>

<p class=MsoNormal><u><span lang=EN-US>Non-invasive prenatal diagnosis of
monogenic disorders (NIPD-M)</span></u><span lang=EN-US> </span></p>

<p><span lang=EN-US>Blouin JL, Rieubland C and Nouspikel T. <i>Fetal Fraction
Signatures: A Quality Control Tool to Detect Potentially Confounding Situations
in NonInvasive Prenatal Diagnosis of Monogenic Conditions</i>. <b>Clin Genet</b>.
doi: 10.1111/cge.70121 (2025).</span></p>

<p>Schwitzgebel, VM, Blouin, JL, Dehos, B, Koehler-Ballan, B, Puder, JJ,
Rieubland, C, Triantafyllidou, M, Zanchi, A, Abramowicz, M, and Nouspikel, T. <i>Enhancing
Fetal Outcomes in GCK-MODY Pregnancies: A Precision Medicine Approach via
Non-Invasive Prenatal GCK Mutation Detection. </i><b>Frontiers in Medicine</b>
11:1347290(2024)</p>

<p>Fokstuen, S, Quteineh, L, Schwitzgebel, VM, Koehler-Ballan, B, Blouin, JL,
Abramowicz, M, and Nouspikel, T. <i>Noninvasive prenatal diagnosis of Mendelian
disorders for consanguineous couples by relative genotype dosage. </i><b>Clin
Genet</b>. 104:505-515. (2023)</p>

<p>Nouspikel, T, Blouin, J-L, Puder, JJ, Koehler-Ballan, B, and Schwitzgebel,
VM. <i>Precision medicine in diabetes: A non-invasive prenatal diagnostic test
for the determination of fetal glucokinase mutations.</i> <b>Journal of
Diabetes Investigation</b> 13:256-261 (2022)</p>

<p class=MsoNormal>&nbsp; </p>

<p class=MsoNormal><u><span lang=EN-US>Circulating tumor DNA (liquid biopsy)</span></u></p>

<p>Nouspikel, T. <i>Digging deep or spreading wide?a comparison of polymerase
chain reaction and sequencing approaches in the analysis of circulating tumor
DNA. </i><b>Precision Cancer Medicine </b>3:13-21 (2020)</p>

<p>Koessler, T, Paradiso, V, Piscuoglio, S, Nienhold, R, Ho, L, Christinat, Y,
Terracciano, LM, Cathomas, G, Wicki, A, McKee, TA, Nouspikel, T. <i>Reliability
of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor
DNA extraction and sequencing with different platforms. </i><b>Laboratory
Investigation </b>100: 1475-1484 (2020)</p>

<p>Friedlaender, A, Nouspikel, T, Christinat, Y, Ho, L, McKee, T, Addeo, A. <i>Tissue-Plasma
TMB Comparison and Plasma TMB Monitoring in Patients With Metastatic Non-small
Cell Lung Cancer Receiving Immune Checkpoint Inhibitors. </i><b>Frontiers in
Oncology </b>10:142-149 (2020)</p>

<p>Koessler T, Addeo A, and Nouspikel T<i>. Implementing circulating tumor DNA
analysis in a clinical laboratory: a user manual</i>. <b>Advances in Clinical
Chemistry</b> 89:131-188 (2019).</p>

<p>Nikolaev, S, Lemmens, L, Koessler, T, Blouin, J-L, and Nouspikel,T<span
lang=EN-US>. </span><i>Circulating tumoral DNA: Preanalytical validation and
quality control in a diagnostic laboratory</i><i><span lang=EN-US>. </span></i><b>Anal.
Biochem.</b> 542: 34-39 (2018)</p>

<p class=MsoNormal>&nbsp; </p>

<p class=MsoNormal><u>DNA repair in differentiated cells</u> </p>

<p>Nouspikel T<span lang=EN-US>. </span>Genetic instability in human embryonic
stem cells: prospects and caveats. Future Oncol. 9:867-77 (2013).</p>

<p>Hyka-Nouspikel, N, Desmarais, J, Gokhale, PJ, Jones, M, Meuth, M, Andrews,
PA, and Nouspikel, T. <i>Deficient DNA damage response and cell cycle
checkpoints lead to accumulation of point mutations in human embryonic stem
cells. </i><b>Stem Cells </b>30:1901-1910 (2012)</p>

<p>Lu, WT, Lemonidis, K, Drayton, RM, and Nouspikel, T<span lang=EN-US>. </span><i>The
Fanconi anemia pathway is downregulated upon macrophage differentiation through
two distinct mechanisms. </i><b>Cell Cycle</b> 10:3300-3310 (2011)</p>

<p>Hyka-Nouspikel, N, Drayton, RM, Lemonidis, K, and Nouspikel, T<span
lang=EN-US>. </span><i>Circulating human B lymphocytes are deficient in
nucleotide excision repair and accumulate mutations upon proliferation. </i><b>Blood
</b><i>117:6277-6286 </i>(2011)</p>

<p>Nouspikel T. <i>DNA repair in mammalian cells : Nucleotide excision repair:
variations on versatility.</i> <b>Cell Mol Life Sci.</b> 66:994-1009 (2009).
Review<span lang=EN-US>.</span><span lang=EN-US> </span></p>

<p class=MsoNormal>Nouspikel T. <i>Nucleotide excision repair and neurological
diseases.</i><b>DNA Repair</b> 7:1155-67 (2008). Review. </p>

<p>Nouspikel, T. and Hanawalt, P.C.<i> Impaired nucleotide excision repair upon
macrophage differentiation is corrected by E1 ubiquitin-activating enzyme.</i><span
class=ti><b>Proc Natl Acad Sci USA</b>.</span> 103:16188-93 (2006)<span
class=ti>.</span> </p>

<p>Nouspikel, T. Hyka-Nouspikel, N., Hanawalt, P.C.&nbsp;<i>Transcription
domain-associated repair in human cells.</i><span class=ti><b>Mol Cell Biol</b>
26:8722-8730 (2006)</span> <br>
<b><br>
</b>Nouspikel, T.&nbsp;<i>DNA repair in differentiated cells: Some new answers
to old questions.<b> </b></i><span class=ti><b>Neuroscience&nbsp;</b>145:1213-1221
(2007)</span> <br>
<br>
<span class=ti>Hsu, P.H., Hanawalt, P.C., and Nouspikel, T.&nbsp;</span><i>Nucleotide
excision repair phenotype of human acute myeloid leukemia cell lines at various
stages of differentiation.&nbsp;</i><b>Mut Research</b> 614:3-15 (2007) </p>

<p>Nouspikel,T. and Hanawalt, P.C. <i>When parsimony backfires: neglecting DNA
repair may doom neurons in Alzheimer's disease.</i> <b>BioEssays</b> 25:168-173
(2003) </p>

<p>Nouspikel,T. and Hanawalt, P.C. <i>DNA repair in terminally differentiated
cells.</i> <b>DNA Repair</b> 1:59-75 (2002) </p>

<p>Nouspikel, T., and Hanawalt, P.C. <i>Terminally differentiated human neurons
repair transcribed genes but display attenuated global DNA repair and
modulation of repair gene expression.</i> <b>Mol. Cel. Biol.</b> 20:1562-1570
(2000) </p>

<p>&nbsp; </p>

<p><u>Role of XPG in xeroderma pigmentosum and Cockayne syndrome</u> </p>

<p>Thorel, F., Constantinou, A., Dunand-Sauthier, I., Nouspikel, T., Lalle, P.,
Raams, A., Jaspers, N.G., Vermeulen, W., Shivji, M.K., Wood, R.D., and
Clarkson, S.G.&nbsp;<i>Definition of a short region of XPG necessary for TFIIH
interaction and stable recruitment to sites of UV damage.</i><b>Mol Cell Biol.</b>
24:10670-80 ( 2004) </p>

<p>Lalle, P., Nouspikel, T., Constantinou, A., Thorel, F., and Clarkson, S.G. <i>The
founding members of xeroderma pigmentosum group G produce XPG protein with
severely impaired endonuclease activity.</i> <b>J. Invest. Dermatol.</b>
118:344-51 (2002) </p>

<p>Nouspikel, T., Lalle, P., Leadon, S.A., Cooper, P.K., and Clarkson S.G. <i>A
common mutational pattern in Cockayne syndrome patients&nbsp; from xeroderma
pigmentosum group G: Implications for a second XPG function</i>. <b>Proc. Natl.
Acad. Sci. USA</b> 94:3116-3121 (1997) </p>

<p>Nouspikel, T. and Clarkson, S. G. <i>Mutations that disable the DNA repair
gene XPG in a xeroderma pigmentosum group G patient.</i> <b>Hum. Mol. Genet.</b>
3:963-967 (1994)<a
href="../../Users/Users/Thierry/AppData/Roaming/Microsoft/abstract.htm#Hum%20Mol%20Genet%201994%20Jun;3%286%29:963-7"></a>
</p>

<p>Scherly, D., Nouspikel, T., Corlet, J., Ucla, C., Bairoch, A., and Clarkson,
S. G. <i>Complementation of the DNA repair defect in xeroderma pigmentosum
group G cells by a human cDNA related to yeast RAD2.</i> <b>Nature </b>363:182-184
(1993) <br>
&nbsp; </p>

<p><u>Glucokinase in primary rat hepatocytes</u> </p>

<p>Nouspikel,T. and Iynedjian, P. B. <i>Insulin signaling and regulation of
glucokinase gene expression in cultured hepatocytes.</i> <b>Eur. J. Biochem</b>.
210:365-373 (1992) </p>

<p>Nouspikel,T., Gjinovci, A., Li, S., and Iynedjian, P. B. <i>Unimpaired
effect of insulin on glucokinase gene expression in hepatocytes challenged with
amylin.</i>&nbsp; <b>FEBS Lett.</b> 301:115-118 (1992) </p>

<p>Iynedjian, P. B., Pilot, P.-R., Nouspikel, T., Milburn, J. L., Quaade, C.,
Hughes, S., Ucla, C., Newgard, C. B. <i>Differential expression and regulation
of the glucokinase gene in liver and islet of Langerhans.</i><b>Proc. Natl.
Acad. Sci. USA</b> 86, 7838-7842 (1989) </p>

<p>Iynedjian, P. B., Jotterand, D., Nouspikel, T., Asfari, M., and Pilot, P.-R.
<i>Transcriptional induction of glucokinase gene by insulin in cultured liver
cells and its repression by the glucagon-cAMP system</i>. <b>J. Biol. Chem.</b>
264, 21824-21829 (1989) </p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><i><span lang=EN-US>Last updated: February 2026</span></i></p>

</div>

</body>

</html>
